Zealand Pharma A/S
(NASDAQ : ZEAL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc. 3.04%92.771.9%$1227.50m
JNJJohnson & Johnson 1.11%148.600.7%$1059.48m
BMYBristol-Myers Squibb Co. -0.15%59.721.0%$1024.94m
PFEPfizer Inc. -0.16%38.120.9%$854.75m
MRKMerck & Co., Inc. 2.10%80.700.7%$839.97m
LLYEli Lilly & Co. 1.71%153.221.1%$505.05m
AZNAstraZeneca Plc 2.04%54.591.2%$279.84m
NVSNovartis AG 1.39%87.480.2%$155.07m
GSKGlaxoSmithKline Plc 0.96%41.940.2%$138.99m
NVONovo Nordisk A/S 1.52%65.950.1%$91.79m
SNYSanofi 0.88%49.110.2%$75.33m
RGENRepligen Corp. 1.36%130.977.1%$69.36m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 8.29%62.590.0%$47.83m
TPTXTurning Point Therapeutics, Inc. 0.99%69.250.0%$40.47m
ARCTArcturus Therapeutics Holdings, Inc. 5.99%38.940.0%$37.16m

Company Profile

Zealand Pharma A/S is a biotechnology company that engages in the discovery, design and development of peptide based medicines. Its products include Soliqua and Lyxumia. The company was founded by Lars Hellerung Christiansen and Bjarne Due Larsen on October 19, 1998 and is headquartered in Soborg, Denmark.